Evidence map›Paper›PMID 40568008›Full record

ArticleOpen forum infectious diseases2025

Clinical Spectrum and Dynamics of Sequelae Following Tick-Borne Encephalitis Virus Infection: A Systematic Literature Review.

Kate Halsby, Liesl Gildea, Pingping Zhang, Frederick J Angulo, Andreas Pilz, Jennifer Moisi, Ann Colosia, Johann Sellner

Erratum issuedAbstract read
In one paragraph

Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Kate HalsbyGlobal Vaccines and Anti-Infectives Medical Affairs, Pfizer, Surrey, United Kingdom.
Liesl GildeaValue and Access, RTI Health Solutions, Manchester, United Kingdom.
Pingping ZhangMedical Affairs Evidence Generation Statistics, Pfizer Research and Development, Collegeville, Pennsylvania, USA.
Frederick J AnguloGlobal Vaccines and Anti-Infectives Medical Affairs, Pfizer, Collegeville, Pennsylvania, USA.
Andreas PilzGlobal Vaccines and Anti-Infectives Medical Affairs, Pfizer, Vienna, Austria.
Jennifer MoisiGlobal Vaccines and Anti-Infectives Medical Affairs, Pfizer, Paris, France.
Ann ColosiaValue and Access, RTI Health Solutions, Durham, North Carolina, USA.
Johann SellnerDepartment of Neurology, Landesklinikum Mistelbach-Gänserndorf, Mistelbach, Austria affiliated with Karl Landsteiner University of Health Sciences, Krems, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Infection with the tick-borne encephalitis virus (TBEV) can affect the nervous system and lead to significant morbidity. To summarize current knowledge of long-term outcomes following TBEV infection, we systematically reviewed the prevalence of TBEV infection sequelae after hospital discharge across different age groups and follow-up time points. Methods: Studies of adults, children, and "all-age" populations with laboratory-confirmed TBEV infection were identified via electronic database searches. Study categorization was based on follow-up time after hospital discharge: ≤6, 7 to ≤12, or >12 months. Sequelae signs/symptoms were divided into 3 categories: neurological, neuropsychiatric, and other. Data were normalized using weighted means. Heterogeneity was estimated using a meta-analytic random-effects model. Results: Fifteen studies were eligible for analysis (13 included only hospitalized patients). Seventy-nine unique sequelae symptoms were identified. Adults had a higher frequency of persistent symptoms than children (20.6%-100% vs 1.7%-69%). There were high levels of data heterogeneity ( Conclusions: Patients experience a variety of neurological, neuropsychiatric, or other sequelae symptoms following TBEV infection that vary over time and across age groups. This study highlights the need for standardized symptom categorization and follow-up time for TBE sequelae studies.

Indexed as

clinical manifestationslong-term outcomenervous system damagesequelaetick-borne encephalitis

Identifiers

PMID40568008
PMCPMC12188206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.